Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01443884 · ClinicalTrials.gov registry record · NA
Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01443884 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 24 participants.
The verdict
NCT01443884, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of the study is to determine whether grape consumption can reduce the risk of cardiovascular disease by reducing the presence of inflammatory molecules and positively altering cholesterol levels, lipid profiles, and immune cell responses.
Interventions
- DIETARY_SUPPLEMENT Grape powder, followed by placebo powder
- DIETARY_SUPPLEMENT Placebo powder followed by grape powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01443884
The ClinicalTrials.gov registry entry for NCT01443884 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Grape powder, followed by placebo powder is the first listed.
NCT01443884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01443884 about?
NCT01443884 is a clinical study titled "Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease". The goal of the study is to determine whether grape consumption can reduce the risk of cardiovascular disease by reducing the presence of inflammatory molecules and positively altering cholesterol levels, lipid profiles, and immune cell responses.
What is the current status of trial NCT01443884?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2009-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01443884?
The interventions under investigation include: Grape powder, followed by placebo powder (DIETARY_SUPPLEMENT), Placebo powder followed by grape powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01443884?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.